{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:24:33Z","timestamp":1780716273006,"version":"3.54.1"},"reference-count":114,"publisher":"Informa Healthcare","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2014,12,1]]},"DOI":"10.1185\/03007995.2014.969566","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T08:45:17Z","timestamp":1411548317000},"page":"2589-2606","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":20,"title":["Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies"],"prefix":"10.1185","volume":"30","author":[{"given":"Pierre-Michel","family":"Llorca","sequence":"first","affiliation":[{"name":"Centre Hospitalier Universitaire\rClermont-FerrandFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lan\u00e7on","sequence":"additional","affiliation":[{"name":"Hopital Sainte-Marguerite CHU\rMarseilleFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Brignone","sequence":"additional","affiliation":[{"name":"Lundbeck SAS\rParisFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Rive","sequence":"additional","affiliation":[{"name":"Lundbeck SAS\rParisFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Salah","sequence":"additional","affiliation":[{"name":"Keyrus Biopharma\rParisFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Ereshefsky","sequence":"additional","affiliation":[{"name":"PAREXEL International\rGlendale, CaliforniaUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Francois","sequence":"additional","affiliation":[{"name":"Lundbeck SAS\rParisFrance"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3197","published-online":{"date-parts":[[2014,10,10]]},"reference":[{"key":"CIT0001","unstructured":"World Health Organization. Depression [fact sheet no. 369]. 2012; Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs369\/en\/ [Last accessed 11 September 2014]"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2003.07.004"},{"key":"CIT0003","first-page":"983","volume":"36","author":"Conti DJ","year":"1994","journal-title":"J Occupational Med"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1359"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.07.018"},{"key":"CIT0006","unstructured":"European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment of depression. 2013. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/05\/WC500143770.pdf [Last accessed 1 August 2014]"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07470"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3283542457"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200202000-00007"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2013.02.016"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06191"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300059"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711001027"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112441866"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.761600"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.725035"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000727"},{"key":"CIT0018","unstructured":"Mahableshwarkar AR, Jacobsen PL, Serenko M, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of 2 doses of vortioxetine in adults with major depressive disorder. Available at: http:\/\/www.psychiatry.org\/learn\/library\u2013archives [Last accessed 2 August 2013]"},{"key":"CIT0019","unstructured":"European Medicines Agency. Note for guidance on choice of control group in clinical trials. 2001. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002925.pdf [Last accessed 2 August 2013]"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12m08001"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(94)90041-8"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09060820"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60978-8"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00151.x"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.08.796"},{"key":"CIT0026","doi-asserted-by":"crossref","unstructured":"Glenny A-M, Altman D, Song F, et al. Indirect comparisons of competing interventions. Health Technol Assess 2005;9:1-134, iii-iv","DOI":"10.3310\/hta9260"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60046-5"},{"key":"CIT0028","first-page":"661","volume":"10","author":"Olie JP","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"CIT0029","unstructured":"European Medicines Agency. CHMP Assessment Report for Valdoxan (Agomelatine). EMEA\/655251\/2008. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/000915\/WC500046226.pdf [Last accessed September 2013]"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2005.09.002"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200209000-00004"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05471blu"},{"key":"CIT0033","unstructured":"Novartis. Clinical Trial Results Database. CAGO 178A2302. 2008. Available at: http:\/\/www.novctrd.com\/ctrdWebApp\/clinicaltrialrepository\/displayFile.do?trialResult=2626 [Last accessed August 2013]"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181d420a7"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32830cebed"},{"key":"CIT0036","unstructured":"Food and Drug Administration. Review and Evaluation of Clinical Data \u2013 Desvenlafaxine. NDA 21-991. 2008. Available at: http:\/\/drl.ohsu.edu\/cdm\/landingpage\/collection\/fdadrug [Last accessed August 2013]"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.07.006"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802161923"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32830263de"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1097\/01.pra.0000426323.59698.64"},{"key":"CIT0041","unstructured":"Pfizer. Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder (NCT00798707). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00824291?term=NCT00824291&rank=1 [Last accessed September 2013]"},{"key":"CIT0042","unstructured":"Pfizer. Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder (NCT00824291). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00824291?term=NCT00824291&rank=1 [Last accessed September 2013]"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-94"},{"key":"CIT0044","unstructured":"Pfizer. Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder (NCT00863798). Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00863798?term=NCT00863798&rank=1 [Last accessed September 2013]"},{"key":"CIT0045","unstructured":"European Medicines Agency. Withdrawal Assessment Report for ELLEFORE. 2009. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Application_withdrawal_assessment_report\/2010\/01\/WC500064246.pdf [Last accessed August 2013]"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1105"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n0504"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3281e2c84b"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900020046"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0407"},{"key":"CIT0051","unstructured":"Lilly. Clinical Study Summary: Study F1J-MC-HMBH (Study Group A). 2004. Available at: http:\/\/www.lillytrials.com\/results\/Cymbalta.pdf [Last accessed September 2013]"},{"key":"CIT0052","unstructured":"Lilly. Clinical Study Summary: Study F1J-MC-HMBH (Study Group B). 2004. Available at: http:\/\/www.lillytrials.com\/results\/Cymbalta.pdf [Last accessed September 2013]"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X188107"},{"key":"CIT0054","unstructured":"Lilly. Clinical Study Summary: Study F1J-US-HMCR (Study Group A). 2007. Available at: http:\/\/www.lillytrials.com\/results\/Cymbalta.pdf [Last accessed September 2013]"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2004.01.002"},{"key":"CIT0056","unstructured":"Lilly. Clinical Study Summary: Study F1J-MC-HMAY (Study Group A). 2005. Available at: http:\/\/www.lillytrials.com\/results\/Cymbalta.pdf [Last accessed September 2013]"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000132448.65972.d9"},{"key":"CIT0058","unstructured":"Lilly. Clinical Study Summary: Study F1J-MC-HMAT (Study Group B). 2004. Available at: http:\/\/www.lillytrials.com\/results\/Cymbalta.pdf [Last accessed September 2013]"},{"key":"CIT0059","unstructured":"Lilly. Clinical Study Summary: Study F1J-MC-HMAT (Study Group A). 2004. Available at: http:\/\/www.lillytrials.com\/results\/Cymbalta.pdf [Last accessed September 2013]"},{"key":"CIT0060","unstructured":"Lilly. Clinical Study Summary: Study F1J-MC-HMAQ (Study Group A). 2004. Available at: http:\/\/www.lillytrials.com\/results\/Cymbalta.pdf [Last accessed September 2013]"},{"key":"CIT0061","unstructured":"Lilly. Clinical Study Summary: Study F1J-MC-HMAQ (Study Group B). 2004. Available at: http:\/\/www.lillytrials.com\/results\/Cymbalta.pdf [Last accessed September 2013]"},{"key":"CIT0062","unstructured":"Lilly. Clinical Study Summary: Study F1J-MC-HMAY (Study Group B). 2006. Available at: http:\/\/www.lillytrials.com\/results\/Cymbalta.pdf [Last accessed September 2013]"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e3181591c09"},{"key":"CIT0064","unstructured":"Forest Laboratories Inc. Synopsis Clinical Study Report. SCT-MD-13. 2005. Available at: http:\/\/www.forestclinicaltrials.com\/CTR\/CTRController\/CTRHome [Last accessed September 2013]"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0410"},{"key":"CIT0066","unstructured":"Forest Laboratories Inc. Synopsis Clinical Study Report. SCT-MD-01. 2005. Available at: http:\/\/www.forestclinicaltrials.com\/CTR\/CTRController\/CTRHome [Last accessed September 2013]"},{"key":"CIT0067","unstructured":"Food and Drug Administration. Review and Evaluation of Clinical Data \u2013 Escitalopram. NDA 21-232. 2001. Available at: http:\/\/drl.ohsu.edu\/cdm\/landingpage\/collection\/fdadrug [Last accessed August 2013]"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000074988.54339.7c"},{"key":"CIT0069","unstructured":"Lundbeck A\/S. Clinical Trial Report Summary \u2013 Study 99003. 2005. Available at: http:\/\/www.lundbeck.com\/upload\/trials\/files\/pdf\/completed\/99003_CTRS_final_30Dec2005.pdf [Last accessed August 2013]"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200205000-00001"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300768"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2268-5"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.01.007"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1104"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1277"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(00)00957-4"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00178-8"},{"key":"CIT0078","unstructured":"Food and Drug Administration. Review and Evaluation of Clinical Data \u2013 Sertraline. NDA 19-839. 1997. Available at: http:\/\/drl.ohsu.edu\/cdm\/landingpage\/collection\/fdadrug [Last accessed August 2013]"},{"key":"CIT0079","first-page":"18","volume":"51","author":"Reimherr FW","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v59n0305"},{"key":"CIT0081","unstructured":"Food and Drug Administration. Review and Evaluation of Clinical Data \u2013 Venlafaxine IR. NDA 20-151. 1993. Available at: http:\/\/drl.ohsu.edu\/cdm\/landingpage\/collection\/fdadrug [Last accessed August 2013]"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000194645.70869.3b"},{"key":"CIT0083","first-page":"104","volume":"55","author":"Schweizer E","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"CIT0084","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199404000-00003"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.3109\/10401239709147791"},{"key":"CIT0086","unstructured":"Food and Drug Administration. Review and Evaluation of Clinical Data \u2013 Venlafaxine XR. NDA 20-699. 1997. Available at: http:\/\/drl.ohsu.edu\/cdm\/landingpage\/collection\/fdadrug [Last accessed August 2013]"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(99)00067-1"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0904"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06596"},{"key":"CIT0090","unstructured":"Forest Laboratories Inc. Synopsis Clinical Study Report. SCSR_GNSC-04-DP-02_final. 2007. Available at: http:\/\/www.forestclinicaltrials.com\/CTR\/CTRController\/CTRHome [Last accessed September 2013]"},{"key":"CIT0091","unstructured":"Food and Drug Administration. Review and Evaluation of Clinical Data \u2013 Vilazodone. NDA 22-567. 2010. Available at: http:\/\/drl.ohsu.edu\/cdm\/landingpage\/collection\/fdadrug [Last accessed August 2013]"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.08m04637"},{"key":"CIT0093","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.11.008"},{"key":"CIT0094","first-page":"1408","volume":"26","author":"Boulenger JP","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"CIT0095","unstructured":"Mahableshwarkar AR, Jacobsen PL, Serenko M, et al. A duloxetine-referenced fixed dose study comparing efficacy and safety of 2 vortioxetine doses in the acute treatment of adult patients with MDD. 2013. Available at: http:\/\/www.psychiatry.org\/learn\/library\u2013archives [Last accessed August 2013]"},{"key":"CIT0096","unstructured":"Jacobsen PL, Mahableshwarkar AR, Serenko M, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10mg and 20mg in adults with major depressive disorder. 2013. Available at: http:\/\/www.psychiatry.org\/learn\/library\u2013archives [Last accessed August 2013]"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"CIT0098","first-page":"218","volume":"338","author":"Guy W","year":"1976","journal-title":"Volume DHEW Publ No ADM 76"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1002\/0470092602.ch3"},{"key":"CIT0100","unstructured":"European Medicines Agency. Guideline on Missing Data in Confirmatory Clinical Trials. 2010. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2010\/09\/WC500096793.pdf [Last accessed 2 August 2013]"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1002\/0470023589"},{"key":"CIT0102","volume-title":"Meta-analysis of Controlled Clinical Trials","author":"Whitehead A","year":"2003"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-6-30"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X0800800403"},{"key":"CIT0106","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins JP"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60977-6"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-11-201112060-00009"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1187"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(13)70652-7"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109102779"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2005.07.006"},{"key":"CIT0113","doi-asserted-by":"crossref","unstructured":"Falissard B. Treatment of the mind, treatment of the brain: the same evidence-based medicine for both? Paris: 20th World Congress of the IACAPAP, 2012","DOI":"10.1016\/j.neurenf.2012.04.029"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7387.472"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007995.2014.969566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T19:38:04Z","timestamp":1599421084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007995.2014.969566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,10]]},"references-count":114,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12,1]]}},"alternative-id":["10.1185\/03007995.2014.969566"],"URL":"https:\/\/doi.org\/10.1185\/03007995.2014.969566","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-10-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}